Synthetic Biologics Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
43.00
20.00
72.00
157.00
245.00
272
Gross Income
43.00
20.00
72.00
157.00
245.00
272
SG&A Expense
12,296.00
20,482.00
40,908.00
39,095.00
26,006.00
17,299
EBIT
12,339.00
20,502.00
40,980.00
39,252.00
26,251.00
17,571
Unusual Expense
-
620.00
3,811.00
11,412.00
10,738.00
4,083
Non Operating Income/Expense
12.00
95.00
-
-
-
-
Pretax Income
12,318.00
19,784.00
44,785.00
27,803.00
15,492.00
13,421
Consolidated Net Income
12,318.00
19,784.00
44,785.00
27,803.00
15,492.00
13,421
Net Income
12,317.00
19,784.00
43,737.00
27,255.00
15,174.00
13,367
Net Income After Extraordinaries
12,317.00
19,784.00
43,737.00
27,255.00
15,174.00
13,367
Net Income Available to Common
12,317.00
19,784.00
43,737.00
27,255.00
22,136.00
25,291
EPS (Basic)
9.44
11.20
18.90
10.15
6.30
4.06
Basic Shares Outstanding
1,304.80
1,769.90
2,305.90
2,694.00
3,553.30
6,232.40
EPS (Diluted)
9.44
11.18
18.97
10.12
6.23
4.06
Diluted Shares Outstanding
1,304.80
1,769.90
2,305.90
2,694.00
3,553.30
6,232.40
EBITDA
12,296.00
20,482.00
40,908.00
39,095.00
26,006.00
17,299
Non-Operating Interest Income
33.00
3.00
6.00
37.00
21.00
67
Minority Interest Expense
1.00
-
1,048.00
548.00
318.00
54
Preferred Dividends
-
-
-
-
6,962.00
11,924
About Synthetic Biologics
View Profile
